Advirna Genomics
UEI: GY5LKW2MX578
• CAGE: 7B1M9
Overview
Awardee Type
Parent
Company Description
Innovative solutions for delivery of polynucleotides in vivo and ex vivo
for self-delivery of RNAi therapeutics. Develop, validate and provide fully
modified sdRNA oligonucleotides for specific gene knockdowns in vivo and ex
vivo, including hard-to-transfect cell lines. Your Partner in
Oligonucleotide Therapeutics
Name
Advirna Genomics
Website
Headquarters
Westborough, MA
United States
United States
Most Recent Award
Sept. 24, 2021
Calculating
Federal contract recipient
ADVIRNA GENOMICS, INC.
(UEI GY5LKW2MX578, CAGE 7B1M9)
is headquartered in Westborough MA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in January 2012 and
federally registered in
January 2015.
Federal Award Analysis
Advirna Genomics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ADVIRNA GENOMICS, INC.
UEI
GY5LKW2MX578
CAGE Code
7B1M9
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 9, 2012
Initial Registration
Jan. 7, 2015
Last Registration
March 11, 2023
Registration Activation
Feb. 11, 2022
Registration Expiration
March 11, 2023
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
MA
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
Yes